Although loneliness affects a slate of health outcomes, its strongest effects appear to target mental health and overall well-being, according to a comprehensive review and meta-analysis published online in Psychiatry Research.
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the research needed to improve clinicians' understanding of cognition in patients with major depressive disorder.
Contrary to researchers’ expectations, memory loss and accelerated cognitive decline in older adults with major depression are not caused by greater amyloid beta accumulation in the brain, a study suggests.
The prevalence of depressive symptoms in US adults was more than 3-fold higher in the spring during the COVID-19 pandemic compared with before the pandemic, according to a study published online in JAMA Network Open.
Social anxiety symptoms in children exposed to maternal major depressive disorder (MDD) increased children’s risk of developing depressive symptoms over time, according to a study published in the Journal of Adolescence.
Psych Congress cochair Charles Raison, MD, will give a virtual keynote speech August 20, 2020, for the University of Louisville Depression Center’s annual benefit. The event is free and open to the public.
The US Food and Drug Administration (FDA) recently granted Usona Institute, Madison, Wisconsin, the Breakthrough Therapy designation for psilocybin in the treatment of patients with major depressive disorder (MDD).